PoreWise Ingredient
Avobenzone
Public databaseBUTYL METHOXYDIBENZOYLMETHANE
Avobenzone is a UVA filter. It degrades under UV on its own and is paired with other filters for stability. The strongest evidence comes from a 2013 human trial: In a randomized controlled community trial of 903 adults under 55, daily use of a broad-spectrum SPF 15+ sunscreen slowed skin aging over 4.5 years: the daily-sunscreen group showed 24% less photoaging than the discretionary-use group (relative odds 0.76, 95% CI 0.59 to 0.98). The trial measured the act of using a broad-spectrum sunscreen. 2013 · 903 people · adults under 55 in Nambour, Australia · PMID 23732711 · The trial assigned a broad-spectrum sunscreen. It ran in Australia at a high-UV latitude and stopped at 4.5 years, and the relative effect was modest (24%). 2 products contain Avobenzone; the highest it appears is number 1 of 26.
- Also written as:
- AVOBENZONE
- INCI name:
- BUTYL METHOXYDIBENZOYLMETHANE
- CAS number:
- 70356-09-1
- Source:
- PubChem
Functions
Products with this ingredient
Avobenzone appears on 2 product ingredient lists, most often around number 9; its highest position is number 1 of 26.
| Product | Brand | Where it sits on the list |
|---|---|---|
| Ultra-Light Moisturizing Lotion SPF 30 | CeraVe | 1 of 26 |
| Anthelios UVMune 400 Invisible Fluid SPF50+ (fragrance-free) | La Roche-Posay | 9 of 26 |
Studies and results
- 1 Skin effectSunscreen and prevention of skin aging: a randomized trial
In a randomized controlled community trial of 903 adults under 55, daily use of a broad-spectrum SPF 15+ sunscreen slowed skin aging over 4.5 years: the daily-sunscreen group showed 24% less photoaging than the discretionary-use group (relative odds 0.76, 95% CI 0.59 to 0.98). The trial measured the act of using a broad-spectrum sunscreen.
Human trial · 2013 · 903 people · adults under 55 in Nambour, Australia · Daily use of a broad-spectrum sunscreen in adults under 55 living in a high-UV climate. · The trial assigned a broad-spectrum sunscreen. It ran in Australia at a high-UV latitude and stopped at 4.5 years, and the relative effect was modest (24%).
- 2 Skin effectThe Influence of Sunscreen Use on Skin Pigmentation Disorders: Melasma, Post-Inflammatory Hyperpigmentation, and Vitiligo
A 2026 review of the 2015-2025 literature concluded that sun protection plays a central role in the prevention and treatment of pigmentation disorders including melasma and post-inflammatory hyperpigmentation, and that broad-spectrum sunscreens with visible-light protection may enhance protection against hyperpigmentation.
Review article · 2026 · People with melasma, post-inflammatory hyperpigmentation or vitiligo · People managing or preventing pigmentation disorders, particularly melasma and post-inflammatory hyperpigmentation; those with darker skin phototypes (IV-VI) where visible light can worsen hyperpigmentation. · 2026 · People with melasma, post-inflammatory hyperpigmentation or vitiligo. · PMID 42793277
- 3 Legal limitsCosIng — European Commission cosmetic ingredient database
UV filters are permitted up to the maximum concentrations set by each market's regulation.
Official ingredient listing · Products making a sunscreen claim. Limits differ between the EU, the US and China. · Reapplication and the amount applied matter more than the label. · Ingredient database · AVOBENZONE · HOMOSALATE · OCTISALATE
Skin concerns this ingredient has been studied for
The people in each study had that concern.
Common questions
- What does Avobenzone do in skincare?
- Avobenzone is a UVA filter. It degrades under UV on its own and is paired with other filters for stability.
- Where does Avobenzone sit in these formulas?
- Avobenzone appears in 2 products; highest on the list is number 1 of 26, in Ultra-Light Moisturizing Lotion SPF 30.
- Which products contain Avobenzone?
- Products that contain Avobenzone: Ultra-Light Moisturizing Lotion SPF 30, Anthelios UVMune 400 Invisible Fluid SPF50+ (fragrance-free).
- How strong is the evidence behind Avobenzone?
- 3 findings on Avobenzone; the strongest is a 2013 human trial of 903 adults under 55 in Nambour, Australia.
- What did the study on Avobenzone measure?
- 2013 · 903 people · adults under 55 in Nambour, Australia · PMID 23732711 · The trial assigned a broad-spectrum sunscreen. It ran in Australia at a high-UV latitude and stopped at 4.5 years, and the relative effect was modest (24%).